Delivery Order SPE2DB20D3103-SPE2DB24FQ0Y2

Award Date 8/29/24
Potential Completion Date 9/20/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $27,213.60 firm fixed-price contract is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $2,042.76, is for the supply of VEKLURY 100 MG VIALS, a pharmaceutical product. The contract is a firm fixed-price arrangement with a completion date of September 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which enables the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of VEKLURY 100 MG VIALS, with a ceiling value of $3,962.20 and an ultimate completion date of April 18, 2025. The contract is an Indefinite Delivery Contract (IDC) that serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and...
This is a $4,085.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VEKLURY 100 MG VIALS. The contract has a completion date of September 5, 2024 and was awarded on August 14, 2024. This order is part of a larger indefinite delivery contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,085.52, is for the delivery of VEKLURY 100 MG VIALS, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of December 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of VEKLURY 100 MG VIALS, a pharmaceutical product. The contract is not set aside and has a firm fixed price with a ceiling value of $3,962.10. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, for the supply of VEKLURY 100 MG vials. The order has a ceiling value of $7,490.12 and a completion date of April 1, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued up to $999,999,999.00 through December 31, 2025. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a ceiling value of $13,618.40 and a completion date of August 16, 2024. It is a firm-fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award. The contract supports the federal government's healthcare needs, likely supplying the VEKLURY medication to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,817.84 for the provision of VEKLURY 100 MG VIALS, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,754.64 firm fixed-price delivery order contract is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a comprehensive...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FQ0Y2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,618.40, is for the delivery of VEKLURY 100 MG vials, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order does not have a set-aside designation, indicating open competition. The contract has a firm fixed-price pricing type and a period of performance through September 2024.

Generated 2/27/25, 11:06 AM